• Maximize NIH and DOD Funding

    The FreeMind Group is the premier international consulting firm specializing in assisting life science organizations secure non-dilutive funding from US Federal Agencies and Private Foundations

    Watch Introductory Video
  • Attend the 12th Annual Non-Dilutive Funding Summit

    January 11, 2017 – Marines Memorial Club, San Francisco, CA

    Event HomepageOne step Registration

About Us

The FreeMind Group turns non-dilutive funding into a strategic source of funding for life science organizations

Experience

Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. Our goal is to assist in maximizing potential to receive funding from non-dilutive sources. We have experience in seeking funding from nearly all NIH Institutes, Department of Defense, NSF, FDA, BARDA, etc., as well as private foundations.

Expertise

FreeMind’s knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our expertise in applying for grants and contracts extends throughout every government mechanism as well as private foundations open to funding the life sciences.

Success

FreeMind’s proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. Awards range from $150,000 to $150,000,000 per project. Our team of experts will assist in making non-dilutive funding a key tool in a long-term sound financial strategy.

Leadership

Ram May-Ron

Ram May-Ron

Managing Partner
Ayal Ronen, M.Sc., MBA

Ayal Ronen, M.Sc., MBA

Vice President
Guy Har-Chen, M.Sc., MBA

Guy Har-Chen, M.Sc., MBA

Chief Analyst
Joel Knopf, M.Sc., MBA

Joel Knopf, M.Sc., MBA

Manager of Consulting Services
Sigal Katz, Ph.D.

Sigal Katz, Ph.D.

Senior Analyst
Inna Grodzovski, Ph.D.

Inna Grodzovski, Ph.D.

Senior Analyst
Amit Sadeh, Ph.D.

Amit Sadeh, Ph.D.

Senior Analyst
Ariel Shatz

Ariel Shatz

Executive Vice President

Strategic Partners

  • ebd-group
  • ibf
  • sachs_lge
  • advamed
  • OBN
  • LSN Logo
  • IIR
  • Biotech and Money
  • Asebio
  • AusBiotech
  • demy colton logo

THE PROCESS

  • Strategic Assessment

    Provides a robust, long-term, multi-submission granting strategy for each pipeline project. FreeMind is well versed in the interests, goals, and available funding opportunities of each funding source.

  • Macro Application Strategy

    Outline the specific aims, scope of work, budgetary needs, as well as delineate any collaborators, subcontractors, and consultants required. We devise a timeline to submission and set an orderly division of responsibilities.

  • Grant Production Process

    A combined writing effort, based on comprehensive templates drafted by project managers, yields the work product. The iterative review concludes when a well-structured scientifically sound application materializes.

  • Submission and Follow up

    Upon completion, the application is submitted. Post-submission we closely monitor the review process, and assist with pre-award negotiations, awaiting a final decision by the granting agency.

FreeMind’s knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award

  • FreeMind did unbelievable job- and put in so many hrs today and all throughout the past few weeks. I don’t think we could have done it without such help from FreeMind and all of you!

    Nalini Motwani, Ph.D. - President, BioSavita
  • Many thanks for your excellent support. It was and continues to be our pleasure working with you, and we too look forward to embarking on a new grant project with you again soon.

    Maurits W. Geerlings - Formula Pharmaceuticals
  • Thank you all for your tireless, persistent efforts in pushing this through. We are now well positioned to let the considerable merits of our application shine through. Much appreciated.

    Jonathan Lim - IGNYTA
  • From the Immusoft, Thank you again for your efforts and guidance during the assemblage of our SBIR grant. We have improved our grantsmanship as a result of FMG’s involvement.

    Zach Hall – Immusoft
  • There is no way we would have been able to do it in such a short time without you.
    Thank you for all your help!!!

    Rudy Rodriguez - Advanced Animal Diagnostics
  • After a powerful joint effort as usual, and many careful iterations of edits, this proposal looks top-notch! Thanks to all for your participation in the success of this submission. Thank you Freemind, in particular, your hard work has greatly improved this proposal, you have been a tremendous help, right up to the end.

    Aileen Gibbons - Respira Therapeutics, Inc.
  • Thank you very much. Writing this grant proposal has been very insightful to me, and the Freemind team made it a very smooth process.

    Ed Buurman – Astrazeneca
  • I LOVE working with you guys!! ……..Your true entrepreneurial approach is just what I needed right now…….

    Tim Bertram, Tengion
  • FreeMind has added a lot of value to the proposal, driving us perfectly through the process, the exact role we were expecting

    Luis Ruiz-Avila - Janus Developements
  • We are very satisfied with the role and involvement of FreeMind on our project. All has been submitted on time with a great interaction (and hard work) between our two teams.

    Eric Massou, Poxel
  • Thanks so much for all of your help on this proposal!  I am so grateful that you were available to work with us, and I don’t think we could have done it without you.

    Meghan Norvell, nanoMR
  • You did a fantastic job for Embolx and I continue to recommend FreeMind to entrepreneurs here is Silicon Valley.

    Michael Allen - President and CEO, Embolx

LEARN

Non Dilutive Funding – Non di-lu’-tive Fund-ing

1. funding – financial resources provided to make some project possible; “The National Institutes of Health (NIH) provided funding for the experiment.”

2. non-dilutive funding – the act of financing R&D activity not traded for public securities and/or shares of a commercial entity; “The FreeMind Group assisted in securing non-dilutive funding from the Department of Defense for a Phase II clinical trial.”

Free Educational Webinars

Listen to FreeMind experts and learn about non-dilutive sources of funding relevant to you.

Participation is FREE of Charge, Registration is Required

Upcoming Webinars

Coming soon!

Recent Webinars

November 2, 2016

Introduction to SBIR and STTR Funding Opportunities

more information

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we will discuss process for applying, guidelines, key success components and insight into increasing chances for award.

October 13, 2016

A Look at the National Institute of Diabetes and Digestive and Kidney Diseases

more information

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) supports research on many of the most common, costly, and chronic conditions to improve health.

With a FY2016 budget of over $1.8 Billion, the NIDDK supports R&D from basic research and early discovery stage projects all the way through late stage clinical trials. The NIDDK funds research in a wide variety of topics including Diabetes, Weight Management, Digestive, Kidney, Liver, Urologic and Endocrine Diseases, Nutrition, and many more.

In this webinar we will discuss:
• The various programs and mechanisms
• The application process
• Guidelines and regulations
• Key success components
• Insight into increasing chances for award

September 7, 2016

Step-by-Step Registration Guide: Smooth Sailing to an Error Free Submission

more information

Registration is a multi-step process that can take 8 weeks or more and MUST be completed before the submission deadline. Organizations must be registered with the System for Award Management (SAM), Grants.gov and eRA Commons.

The registration process is not sequential. As soon as an organization has obtained its DUNS number, it can begin registering with SAM and then Grants.gov and eRA Commons.

All too often organizations struggle with the registration process which can lead to rejected applications and frustration.

In this webinar, we will cover a step-by-step guide to the registration process, including:
– How to obtain a DUNS number
– Registering with grants.gov, SAM, eRA Commons and ASSIST
– Generating other acronyms such as: AOR, eBiz POC, TIN, EIN
– Important tips
– Troubleshooting
– Successful submission!

July 20, 2016

Navigating Your NIH Budget: Pre-and Post Award

more information

In this free webinar, we will discuss the preparation of your budget and we welcome Jameson & Company, LLC to co-present and share more about what you need to know about managing the budget once you’ve won your grant.

Assembling a budget for your grant is typically the last item to be addressed as the figures you are suggesting must reflect the work you are proposing to complete. That said, simply stating the cost per item is hardly enough.

A properly constructed justification is mandatory and weighs heavily on approval of your budget. When comprising the budget, one must ensure an accurate completion of the document while adhering to NIH guidelines and stipulations. Items such as indirect costs, sub-contractors, sub-awards, salaries, and even travel expenses must be completed correctly. This becomes increasingly difficult when large and complex applications have several budgets feeding into one.

In this live presentation, you will discover:
• What are the different sections of the NIH budget
• What are calendar months and how they are calculated
• How to create your budget justification
• Recent changes to the budget forms in grant applications
• Budget forms and formats in ASSIST
• Potential pitfalls and how to avoid them
• What you need to do to have an acceptable accounting system
• Two quick questions you can ask you accountant and KNOW if you are ok or not
• The annual True-Up report that you need to prepare
• How and when that True-Up report gets audited
• The most common mistakes to avoid
• The cost of non-compliance
• Federal Acquisition Regulations: Part 30 & 31

May 18, 2016

Funding Opportunities for Pre-Clinical Stage Research

more information

Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences.

Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private foundations. The NIH alone annually funds over $15B to pre-clinical stage R&D in the life sciences.

In this webinar we will the discuss process for applying, guidelines, key success components and insight into increasing chances for award.

The webinars are designed for first timers as well as seasoned grantees. FreeMind experts will share their insight into various areas of interest as they relate to non-dilutive sources of funding and how to maximize chances for award.

For any inquiries, please email Irina Rajkovetsky: Send Mail

All Webinars are recorded and posted on the FreeMind Group Educational YouTube Channel

JOIN A WEBINAR

FreeMind’s knowledgeable team of expert grant writers share their wisdom on how to maximize chances for award.

Join our mailing list by typing in your email address here:

* Don’t worry, we hate spam as much as you do.

Contact us using this form

Contact us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Questions, issues or concerns? I'd love to help you!

Click ENTER to chat